BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 27614956)

  • 1. Ongoing Clinical Trials in Testicular Cancer: The TIGER Trial.
    Oncol Res Treat; 2016; 39(9):553-6. PubMed ID: 27614956
    [No Abstract]   [Full Text] [Related]  

  • 2. Salvage chemotherapy with paclitaxel, ifosfamide, and cisplatin (TIP) in relapsed or cisplatin-refractory germ cell tumors.
    Park S; Lee S; Lee J; Park SH; Park JO; Kang WK; Park YS; Lim HY
    Onkologie; 2011; 34(8-9):416-20. PubMed ID: 21934340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salvage Chemotherapy With Gemcitabine, Paclitaxel, Ifosfamide, and Cisplatin for Relapsed Germ Cell Cancer.
    McKenzie HS; Mead G; Huddart R; White JD; Rustin GJS; Hennig IM; Cozens K; Cross N; Bowers M; Wheater MJ
    Clin Genitourin Cancer; 2018 Dec; 16(6):458-465.e2. PubMed ID: 30115544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conventional-dose versus high-dose chemotherapy as first salvage treatment in male patients with metastatic germ cell tumors: evidence from a large international database.
    Lorch A; Bascoul-Mollevi C; Kramar A; Einhorn L; Necchi A; Massard C; De Giorgi U; Fléchon A; Margolin K; Lotz JP; Germà-Lluch JR; Powles T; Kollmannsberger C; Beyer J
    J Clin Oncol; 2011 Jun; 29(16):2178-84. PubMed ID: 21444870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Should high-dose chemotherapy be used to consolidate second or third line treatment in relapsing germ cell tumours?
    Shamash J; O'Doherty CA; Oliver RT; Kelsey S; Gupta RK; Gallagher CJ; Newland AC; Lister TA
    Acta Oncol; 2000; 39(7):857-63. PubMed ID: 11145445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High dose chemotherapy in germ cell tumors.
    Rosti G; De Giorgi U
    Tunis Med; 2005 Dec; 83 Suppl 12():85-6. PubMed ID: 16430076
    [No Abstract]   [Full Text] [Related]  

  • 7. Multicentric phase II trial of TI-CE high-dose chemotherapy with therapeutic drug monitoring of carboplatin in patients with relapsed advanced germ cell tumors.
    Chevreau C; Massard C; Flechon A; Delva R; Gravis G; Lotz JP; Bay JO; Gross-Goupil M; Fizazi K; Mourey L; Paci A; Guitton J; Thomas F; Lelièvre B; Ciccolini J; Moeung S; Gallois Y; Olivier P; Culine S; Filleron T; Chatelut E
    Cancer Med; 2021 Apr; 10(7):2250-2258. PubMed ID: 33675184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paclitaxel plus Ifosfamide followed by high-dose carboplatin plus etoposide in previously treated germ cell tumors.
    Kondagunta GV; Bacik J; Sheinfeld J; Bajorin D; Bains M; Reich L; Deluca J; Budnick A; Ishill N; Mazumdar M; Bosl GJ; Motzer RJ
    J Clin Oncol; 2007 Jan; 25(1):85-90. PubMed ID: 17194908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salvage combined chemotherapy with paclitaxel, ifosfamide and nedaplatin for patients with advanced germ cell tumors.
    Nakamura T; Ueda T; Oishi M; Nakanishi H; Fujihara A; Naya Y; Hongo F; Kamoi K; Okihara K; Miki T
    Int J Urol; 2015 Mar; 22(3):288-93. PubMed ID: 25393104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequential high-dose chemotherapy protocol for relapsed poor prognosis germ cell tumors combining two mobilization and cytoreductive treatments followed by three high-dose chemotherapy regimens supported by autologous stem cell transplantation. Results of the phase II multicentric TAXIF trial.
    Lotz JP; Bui B; Gomez F; Théodore C; Caty A; Fizazi K; Gravis G; Delva R; Peny J; Viens P; Duclos B; De Revel T; Curé H; Gligorov J; Guillemaut S; Ségura C; Provent S; Droz JP; Culine S; Biron P;
    Ann Oncol; 2005 Mar; 16(3):411-8. PubMed ID: 15659420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I/II study of sequential dose-intensified ifosfamide, cisplatin, and etoposide plus paclitaxel as induction chemotherapy for poor prognosis germ cell tumors by the German Testicular Cancer Study Group.
    Hartmann JT; Gauler T; Metzner B; Gerl A; Casper J; Rick O; Horger M; Schleicher J; Derigs G; Mayer-Steinacker R; Beyer J; Kuczyk MA; Bokemeyer C;
    J Clin Oncol; 2007 Dec; 25(36):5742-7. PubMed ID: 18089869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bevacizumab plus high-dose ifosfamide, etoposide and carboplatin (HD-ICE) as third-line salvage chemotherapy induced an unexpected dramatic response in highly platinum refractory germ-cell cancer.
    Voigt W; Kegel T; Maher G; Jordan K; Müller L; Schmoll HJ
    Ann Oncol; 2006 Mar; 17(3):531-3. PubMed ID: 16234294
    [No Abstract]   [Full Text] [Related]  

  • 13. High-dose chemotherapy and stem-cell rescue for metastatic germ-cell tumors.
    Einhorn LH; Williams SD; Chamness A; Brames MJ; Perkins SM; Abonour R
    N Engl J Med; 2007 Jul; 357(4):340-8. PubMed ID: 17652649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of relapsed/refractory germ cell tumours: an equipoise between conventional and high dose therapy.
    Rashid S; Lim L; Powles T
    Curr Treat Options Oncol; 2012 Jun; 13(2):201-11. PubMed ID: 22623055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [BEP/VIP in children and adolescents with malignant non-testicular germ cell tumors. A comparison of the results of treatment of therapy studies MAKEI 83/86 and 89P/89].
    Göbel U; Calaminus G; Teske C; Bamberg M; Bökkerink JP; Haas RJ; Holschneider AM; Janka-Schaub G; Jürgens H; Mittler U
    Klin Padiatr; 1993; 205(4):231-40. PubMed ID: 7690864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose chemotherapy as salvage treatment in germ-cell cancer: when, in whom and how.
    Lorch A; Beyer J
    World J Urol; 2017 Aug; 35(8):1177-1184. PubMed ID: 27678272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paclitaxel, ifosfamide, and cisplatin (TIP) as salvage and consolidation chemotherapy for advanced germ cell tumor.
    Kurobe M; Kawai K; Oikawa T; Ichioka D; Kandori S; Takaoka E; Kojima T; Joraku A; Suetomi T; Miyazaki J; Nishiyama H
    J Cancer Res Clin Oncol; 2015 Jan; 141(1):127-33. PubMed ID: 25062721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional deep hyperthermia for salvage treatment of children and adolescents with refractory or recurrent non-testicular malignant germ-cell tumours: an open-label, non-randomised, single-institution, phase 2 study.
    Wessalowski R; Schneider DT; Mils O; Friemann V; Kyrillopoulou O; Schaper J; Matuschek C; Rothe K; Leuschner I; Willers R; Schönberger S; Göbel U; Calaminus G;
    Lancet Oncol; 2013 Aug; 14(9):843-52. PubMed ID: 23823158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paclitaxel in salvage therapy for germ cell tumors.
    Motzer RJ
    Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-83-S15-85. PubMed ID: 9346229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose chemotherapy in nonseminomatous germ cell cancer.
    Kollmannsberger C; Beyer J; Bokemeyer C
    BJU Int; 2009 Nov; 104(9 Pt B):1398-403. PubMed ID: 19840020
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.